Giuseppe Musumeci
@giuseppemusum11
ID: 2592986109
08-06-2014 20:20:16
344 Tweet
395 Followers
190 Following
In FOURIER, intensive LDL-C lowering with #evolocumab led to greater CV event reduction in patients with autoimmune or inflammatory diseases. These patients may derive particular benefit from earlier, more intensive lipid-lowering treatments. Robert Giugliano André Zimerman #ACC24
Diabete e cuore, focus in Piemonte con il Diabster Registry s24ore.it/zMCTzY via IlSole24ORE
Join Mamas A. Mamas in room WARSAW #ESCCongress2024 Chairing session on PCSK9 inhibitors for ACS What’s the benefit of starting earlier? Role in long term prevention?